On agonist stimulation, D 1 Rs are recruited by microtubules from the cytoplasm to the apical cell surface. 6, 7 Renal tubular plasma membrane D 1 Rs are further stimulated by dopamine synthesized in the renal proximal tubule cell (RPTC) that is released in a paracrine manner, increasing G-protein coupling and a subsequent activation of AC (adenylyl cyclase) and PKA (protein kinase A). 6, 8 Renal Ang II (angiotensin II) is converted to Ang III by aminopeptidase A, which stimulates AT 2 Rs to decrease Na + transport through an increase in soluble GC (guanylyl cyclase) production of cGMP, which stimulates PKG (protein kinase G; Figure 6 ).
T he renal dopaminergic and renin-angiotensin systems are major regulators of sodium (Na + ) homeostasis. [1] [2] [3] [4] Both D 1 R (dopamine D 1 -like receptors) and AT 2 R (angiotensin II type-2 receptors) are natriuretic receptors, as stimulation by either dopamine or Ang III (angiotensin III), respectively, inhibits renal Na + reabsorption, resulting in natriuresis. 4, 5 On agonist stimulation, D 1 Rs are recruited by microtubules from the cytoplasm to the apical cell surface. 6, 7 Renal tubular plasma membrane D 1 Rs are further stimulated by dopamine synthesized in the renal proximal tubule cell (RPTC) that is released in a paracrine manner, increasing G-protein coupling and a subsequent activation of AC (adenylyl cyclase) and PKA (protein kinase A). 6, 8 Renal Ang II (angiotensin II) is converted to Ang III by aminopeptidase A, which stimulates AT 2 Rs to decrease Na + transport through an increase in soluble GC (guanylyl cyclase) production of cGMP, which stimulates PKG (protein kinase G; Figure 6 ). 9 Previous studies have not determined whether the D 1 R or AT 2 R acts independently or collectively to inhibit renal Na + transport. In rodents, AT 2 Rs are recruited to the RPTC apical plasma membrane on D 1 R stimulation, and the AT 2 R antagonist, PD-123319 (PD), blocks the D 1 R-mediated natriuretic response, suggesting that AT 2 R is necessary for D 1 R activity. 10 In human RPTCs, we and others have reported that D 1 R and AT 2 R activation increases cAMP and cGMP, respectively, leading to a decrease in Na + transport, [11] [12] [13] [14] but the interdependence of D 1 R and AT 2 R stimulation on receptor translocation to the apical plasma membrane is unknown. The goal of this study is to investigate further the relationship between the D 1 R and AT 2 R in human RPTCs. We have reported that the resensitization of the desensitized, phosphorylated D 1 R is dependent on its dephosphorylation by PP2A (protein phosphatase 2A). [15] [16] [17] [18] The current study tests the hypothesis that downstream activation of either D 1 R or AT 2 R converges at PP2A, which is necessary for both receptors to be translocated to the apical cell surface to inhibit Na + transport.
Materials and Methods

Pharmacological Agents
All pharmacological agents were purchased from Sigma-Aldrich. 19 ) is a potent and selective D 1 R antagonist. 20 H-Arg-Val-Tyr-Ile-His-Pro-Phe-OH, Ang III is the preferred endogenous AT 2 R agonist. 21 [4,5-c] pyridine-6-carboxylic acid ditrifluoroacetate, PD is a potent and selective nonpeptide antagonist to the AT 2 R. 22 8-bromoadenosine cyclic 3′,5′-monophosphate (8-Br-cAMP) is a cell-permeable cAMP analog. 8-bromoguanosine cyclic 3′,5′-monophosphate (8-Br-cGMP) is a cell-permeable cGMP analog. 23 Rp-adenosine 3′,5′-cyclic monophosphorothioate triethylammonium salt (Rp-cAMPS) is a PKA antagonist. 24 8-(4-chlorophenylthio) guanosine-3,5-cyclic monophosphorothioate, Rp-isomer triethylammonium salt (Rp-8-CPT-cGMPS) is a PKG antagonist. 25 9,10-deepithio-9,10-didehydroacanthifolicin, okadaic acid (OA) is a PP2A antagonist.
14 Ouabain is a Na + /K + ATPase alpha inhibitor.
3,3′-(4-methyl-1,2-phenylene)bis[N-(aminoiminomethyl)-2-methyl-2-propenamide] dihydrochloride, S3226, is a potent and selective sodium hydrogen exchanger 3 (NHE3) inhibitor 26 .
Human RPTCs
Human kidney tissue and cell culture procedures were followed as reported previously. 27, 28 For more details, please see the online-only Data Supplement.
Quantification of Cell Surface Recruitment of D 1 R and AT 2 R by Flow Cytometry
RPTCs were grown in iPT-G418 media in 100-mm plates for 2 days until 60% to 80% confluence at 37°C in full humidity with 5% CO 2 . Vehicle (VEH; control) and agonists were added to cells, and inhibitors were added 15 minutes before the addition of receptor agonists. Cells were stained in suspension and stained without permeabilization according to details found in the online-only Data Supplement. Treated and stained cells were run on a benchtop flow cytometer with a robotic autoloader (Accuri C6Sampler; Accuri Cytometers, Inc).
Quantification of Cell Surface Recruitment of D 1 R and AT 2 R by 96-Well In-Cell Western
Procedures were followed as reported previously. 29 For more details, please see the online-only Data Supplement.
Biotinylation and Western Blot Analysis
Procedures were followed as reported previously.
14, 28 For more details, please see the online-only Data Supplement.
PP2A Activity Assay
RPTCs at 80% confluence in 100-mm plates were incubated in serum-free DMEM-F12 media with or without agonists, washed, and lysed in phosphate-free buffer, according to kit instructions (Millipore; cat No. 17-313). Briefly, 500 µg of protein was immunoprecipitated using a monoclonal antibody specific for the catalytic subunit of PP2A (clone 1D6). Phosphatase activity was measured by the release of phosphate from a phosphorylated peptide K-R-pT-I-R-R using malachite green by absorbance at 620 nm in a 96-well plate reader (Pherastar FSX; BMG Labtech) and compared with a standard curve made by diluting phosphate directly in malachite green.
NHE3-Mediated Na + Accumulation Assay
Procedures were followed as reported previously. 26 For more details, please see the online-only Data Supplement. 
Effects of 8-Br-cGMP±PKG Inhibitor Rp-8-CPT-cGMPS and the Effects of 8-Br-cAMP±PKA Inhibitor RpcAMPS on D 1 R and AT 2 R Recruitment Measured by Flow Cytometry
Human RPTCs were treated as follows: (1) 
Statistical Analysis
The data are presented as mean±SEM. One-way ANOVA, followed by Tukey test was used to compare ≥3 groups. A 2-tailed Student t test was used to compare 2 groups. P <0.05 was considered statistically significant. 
Dose-Response Analysis of 8-Br-cAMP and 8-Br-cGMP
Dopamine binding to the D 1 R leads to AC activation and accumulation of cAMP. 30 Similarly, Ang III binding to the AT 2 R leads to GC activation and accumulation of cGMP. 31 Using cell-permeable analogs of cAMP and cGMP, 8-Br-cAMP Figure S1A and S1B in the online-only Data Supplement) and 8-Br-cGMP ( Figure  S1C and S1D). For the D 1 R, the half maximal effective concentration (EC 50 ) of 8-Br-cAMP was 296.1 µmol/L (log EC 50 was −3.529), and the EC 50 of 8-Br-cGMP was 144.3 µmol/L (log EC 50 was −3.841). For the AT 2 R, the EC 50 of 8-Br-cAMP was 206.4 µmol/L (log EC 50 was −3.685), and the EC 50 of 8-Br-cGMP was 165.6 µmol/L (log EC 50 was −3.781).
Flow Cytometry Analysis of 8-Br-cAMP, 8-Br-cGMP, or 8-Br-cAMP+8-Br-cGMP Stimulation on D 1 R and AT 2 R Recruitment
The Emax of 1 mmol/L, determined from online-only Data Supplement for both 8-Br-cAMP and 8-Br-cGMP, measured by In-Cell Western experiments, was confirmed using flow cytometry (Figure 2A and 2B ). 8-Br-cAMP, 8-Br-cGMP, or 8-Br-cAMP+8-Br-cGMP significantly increased the plasma membrane recruitment of D 1 R (1.50±0.08-, 1.51±0.08-, and 1.56±0.0-fold, respectively; P<0.05; n=15 per group). 8-Br-cAMP, 8-Br-cGMP, or 8-Br-cAMP+8-Br-cGMP also significantly increased the plasma membrane recruitment of AT 2 R (1.58±0.07-, 1.61±0.06-, and 1.58±0.08-fold, respectively; P<0.05; n=15 per group). Interestingly, the simultaneous addition of both 8-Br-cAMP and 8-Br-cGMP did not cause an additional increase in apical plasma membrane recruitment, relative to either agonist alone. 
Biotinylation and Western Blot
Flow Cytometry Analysis of the Effects of PKG and PKA Inhibitors on Cell Surface D 1 R and AT 2 R Recruitment
To determine, more precisely, the signaling downstream of cAMP and cGMP, we next examined the effect of PKA and PKG inhibition on D 1 R and AT 2 R recruitment in RPTCs. PKA and PKG are inhibited by Rp-cAMPS and Rp-8-CPTcGMPS, respectively, for 15 minutes before 8-Br-cAMP and 8-Br-cGMP stimulation. Exogenous 8-Br-cGMP (1 mmol/L; 30 minutes) increased the apical plasma membrane recruitment of D 1 R (1.56±0.05-fold versus VEH; P<0.05; n=6), which was inhibited in the presence of the PKG inhibitor Rp-8-CPT-cGMPs (100 μmol/L; P<0.05; 8-Br-cGMP+Rp-c8 versus 8-Br-cGMP; n=6). Rp-8-CPT-cGMPS, alone, had no effect ( Figure 3A) . Exogenous 8-Br-cAMP (1 mmol/L; 30 minutes) recruited AT 2 Rs to the cell surface (1.58±0.04-fold versus VEH; P<0.05; n=6), which was inhibited in the presence of the PKA inhibitor Rp-cAMPS (100 μmol/L; P<0.05; 8-Br-cAMP+Rp-cA versus 8-Br-cAMP; n=6). Rp-cAMPS alone had no effect ( Figure 3B ). These results demonstrate that in the absence of PKA or PKG, neither D 1 R nor AT 2 R can be recruited to the cell surface, suggesting important roles for PKA and PKG in D 1 R and AT 2 R recruitment.
Importance of PP2A in D 1 R and AT 2 R Recruitment
We have previously shown that the addition of the D 1 R agonist FEN to RPTCs leads to the activation of PP2A [15] [16] [17] [18] and AT 2 R cell surface recruitment, which are inhibited in the presence of OA. However, we have not tested whether cyclic adenosine monophosphate (cAMP) or cyclic guanosine monophosphate (cGMP) is capable of directly activating PP2A and whether OA is capable of blocking 8-Br-cAMPdependent and 8-Br-cGMP-dependent D 1 R or AT 2 R apical plasma membrane recruitment. Figure 4A depicts the amount of phosphate released from the phosphorylated PP2A target peptide. PP2A activity increased by 1.78±0.12-fold (P<0.05 versus VEH; n=3) after the addition of 8-Br-cAMP. The addition of 8-Br-cGMP also induced a 1.77±0.14-fold increase in PP2A activity (P<0.05; n=3). Either 8-Br-cAMP or 8-Br-cGMP stimulated the recruitment of D 1 Rs to the cell surface (1.50±0.08-and 1.51±0.09-fold, respectively; P<0.05; n=15; Figure 4B ). Either 8-Br-cAMP or 8-Br-cGMP also stimulated the recruitment of AT 2 Rs to the cell surface (1.76±0.05-and 1.79±0.08-fold, respectively; P<0.05; n=15; Figure 4C ). Recruitment of either D 1 R or AT 2 R using cell-permeable downstream second messenger agonists 8-Br-cAMP or 8-Br-cGMP was completely blocked by OA (10 nmol/L)-a specific PP2A inhibitor.
Na
+ Transport-Na + Influx Assay
Both the D 1 R and the AT 2 R, as well as their respective endogenous agonists, dopamine and Ang III, respectively, have been implicated in inhibition of proximal tubule Na + reabsorption that results in natriuresis. Using this cell culture model, we tested whether direct cytoplasmic stimulation with 8-Br-cAMP or 8-Br-cGMP inhibits Na + transport and whether PP2A activity is necessary for this inhibition ( 
Model Depicting Molecular Interactions
The model in Figure 6 summarizes our results. A slice of plasma membrane is depicted with attached microvilli. D 1 R and AT 2 R previously recruited to the apical plasma membrane appear on the membrane surface. Stimulation by D 1 R agonist FEN and the endogenous AT 2 R agonist Ang III (inhibited by the D 1 R and AT 2 R antagonists LE and PD, respectively) causes an increase in D 1 R and AT 2 R recruitment to the apical plasma membrane (solid arrows) through a common serine/ threonine PP2A-mediated mechanism. PP2A is stimulated via the D 1 R stimulation of cAMP production via AC and PKA activation, as well as AT 2 R stimulation of cGMP production via GC and PKG activation.
Discussion
Cell surface membrane recruitment of G-protein-coupled receptors from intracellular compartments is crucial to the renewal of response to autocrine and paracrine agonist stimulation. We have presented evidence that the D 1 R-and AT 2 R-mediated inhibition of RPTC Na + transport is linked to assure redundancy in Na + transport regulation. The cellular messengers associated with these receptors, PKA and PKG, are essential for D 1 R and AT 2 R recruitment through downstream activation via cAMP and cGMP. Previous studies demonstrated that the D 1 R inhibition of renal Na + transport depends on activation of the AT 2 R. 10, 21 Simultaneous stimulation of D 1 R and AT 2 R induces an increase in cGMP. 32 D 1 R stimulation can also induce the recruitment of not only D 1 R but also AT 2 R to the apical brush border membrane of human RPTCs.
14 However, cAMP-, cGMP-, or AT 2 R-stimulated D 1 R translocation has not been reported. In the current study, cell permeant cAMP and cGMP were able to induce both D 1 R and AT 2 R recruitment. The use of both compounds simultaneously does not synergistically or additively increase D 1 R and AT 2 R recruitment to the plasma membrane. The dose chosen for both 8-Br-cAMP and 8-Br-cGMP is the minimum dose that shows maximal translocation of these receptors and may have depleted the limited pool of internalized receptors. Alternatively the doses used could have maximally stimulated a common saturable shared pathway like PP2A. The selectivity of each cyclic nucleotide is quite high because of the relative affinities to their respective kinases, and the dose-response curves show that a dose of one-tenth the chosen dose does not significantly activate recruitment of either receptor, suggesting that direct cross-activation is unlikely. The interdependence of these pathways is supported by the fact that Ang III stimulation of the AT 2 R is also uncoupled to cGMP in the spontaneously hypertensive rat. 33 The D 1 R is also uncoupled from cAMP, in the spontaneously hypertensive rat and Dahl salt-sensitive rat. 34, 35 Future studies will focus on the role of dietary Na + on the synthesis and release of dopamine relative to that of conversion of Ang II to Ang III.
The shared molecular mechanism of how PKA or PKG activation of PP2A leads to translocation of D 1 R and AT 2 R is unknown. GRK4 (G-protein-coupled receptor kinase 4) is known to phosphorylate and inactivate the D 1 R and may be involved in a particular inherited form of human hypertension. 5 β-Arrestin2 is involved with internalization and inactivation of the D 1 R. 36 We hypothesize that PP2A dephosphorylates the D 1 R, releasing the receptor from engagement with this wellstudied internalization mechanism. We have previously shown that the D 1 R and AT 2 R are found together by protein-protein interaction 14 and perhaps are translocated together when released from internal pools.
Renal interstitial cGMP inhibits renal tubule Na + reabsorption via PKG, which regulates Na + excretion. 37, 38 In this study, the inhibition of either PKA or PKG prevents AT 2 R and D 1 R translocation, respectively, to the cell surface. This novel finding further extends the receptor-cAMP/cGMP model to include PKA and PKG, which are also closely linked and that both PKA and PKG need to be present in order for D 1 R and AT 2 R to be recruited to the apical plasma membranes. We also blocked PP2A activity to determine whether this is where these 2 pathways converge and become integrated into 1 signaling mechanism; our previous studies demonstrated the role of PP2A in D 1 R signaling. [15] [16] [17] [18] 39 PKA has been reported to activate PP2A by phosphorylating its regulatory subunit, B56δ. 40 In the renal proximal tubule, B56δ associates with and dephosphorylates NHE3 to facilitate the inhibitory effect of dopamine on NHE3 activity and expression. 41 PP2A has also been reported to be involved in the D 1 R-mediated recruitment of Na + /K + ATPases from cytoplasmic pools into the basolateral membrane and its subsequent inhibition in human adenocarcinoma cells. 39 We now report the convergence of D 1 R-and AT 2 R-mediated inhibition of luminal Na + transport in human RPTCs at PP2A. This effect of PP2A may be a general phenomenon because we have also reported that the D 2 R-mediated inhibition of inflammation is also mediated by PP2A. 42 
Perspectives
Previous studies have not determined whether the D 1 R or AT 2 R acts independently or collectively to inhibit ≤75% of renal Na + transport. The phenomenon of linked G-protein-coupled receptors has not been readily appreciated until recently. Studies by others have demonstrated elaborate interactions, such as allosteric interactions, between monomer receptors either as pairs, oligomers, and receptor mosaic assemblies. These assemblies can inhibit or enhance each other's activities or have an absolute dependence on each other to exert their downstream activities, which is the case for the D 1 R/ AT 2 R interaction. Future studies will focus on determining which other proteins are involved in the Na + transport inhibition, as we found for PP2A, and whether there is symmetrical or asymmetrical allosteric modulation involved in their regulation of Na + transport.
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